Chemomab Therapeutics Ltd.
USD1.69
+0.07 (+4.32%)
CEO
Adi Mor George
IPO Date
2019-02-12
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
IL
Open
$1.71
Prev. Close
$1.62
Day Low
$1.66
Day High
$1.74
52W Low
$1.35
52W High
$4.92
Market Cap
$0.01B
Volume
0.01M
| -2.3 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -142.5% | -109.3% | 0.02 | 4.32 | -0.2 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -76.3% | -64.2% | 0.01 | 6.18 | -1.3 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -20.3% | -19.4% | 0.01 | 23.66 | -5.7 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -55.1% | -47.7% | 0.06 | 9.00 | -8.6 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -219.9% | -137.7% | 0.05 | 4.42 | -1.4 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -140.7% | -108.1% | 0.00 | 3.98 | -7.9 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | 1610.2% | -469.9% | 0.00 | 0.59 | -0.8 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | -143.7% | -83.8% | 0.00 | 2.07 | -9.9 |
| -1.7 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -15.5% | -14.1% | 0.00 | 10.49 | -2.3 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -21.2% | -18.5% | 0.00 | 7.42 | -3.3 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -32.0% | -25.9% | 0.03 | 5.33 | -1.9 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -21.9% | -17.5% | 0.02 | 4.98 | -2.9 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -21.3% | -16.7% | 0.02 | 4.57 | -2.0 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -36.4% | -25.0% | 0.04 | 3.12 | -1.0 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -29.0% | -21.5% | 0.03 | 3.83 | -0.7 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -20.3% | -15.6% | 0.02 | 4.32 | -0.5 |